NFKB1 and metabolic dysfunction-associated steatotic liver disease: It is suggested that DSSG can inhibit lipid peroxidation and downregulate the expression of NF‐κB in liver tissue of NAFLD rats, which may be one of the mechanisms underlying effective treatment of NAFLD.